Effect of early use of levosimendan versus placebo on top of a conventional strategy of inotrope use on a combined morbidity-mortality endpoint in patients with cardiogenic shock.
LevoHeartShock
RecruitingCTIS2024-513811-29-00
CHRU De NancyCardiogenic Shock
Start: 2023-07-03Target: 610Updated: 2025-07-30